Jennifer Preston

Whether it’s the United States of America or any other country in North America, the mental illness problem is getting quite dangerous every day. In the recent report, it’s been found that neighboring country i.e., Canadians are going through some serious issues of mental stress. A survey found out that one out of five Canadians suffers from mental anxiety, which is not only damaging their productivity but also their health. Recently a Canadian court passed a judgment which stated that dismissing a person from their job might lead them to feel inferior and hence go through depression.

People who lost their job from a company or even business might not feel the same, and they are most likely to go through depression or anxiety problems. Experts said they found that employers think obligatory to treat their employees who go through stressful situations. Many big companies have specific divisions related to these things because solving problems relating to these becomes a significant responsibility for them.

Experts said they are witnessing people with depression, anxiety has increased from the last few years, and there needs to be special care taken about it. People who are working in the corporate world are given benefits by some companies of taking leave if they are not feeling good mentally because it would affect their productivity. Insurance companies usually don’t pay claims for illnesses such as depression, anxiety, etc. and that ultimately increases further problems for these people. Deepest think the only way one can get out of such troublesome period is taking time off from these things. Insurance companies not paying those who are depressed clients is still one of the essential topics of discussion in Canada. However, what’s more relevant here is the fact that people with depression, anxiety, and other mental illnesses are increasing every day.

GlaxoSmithKline, Pfizer, Sanofi, and some other drugmakers have decided prices of around 200 drugs in 2020. The price hike is expected to be up to 10 percent across the board, according to Axis Advisors. GlaxoSmithKline said it will raise prices of drugs like Zejula, Ellipta inhaler, and some other products in its HIV-focused ViiV joint venture. There are a total of 30 drugs manufactured by GlaxoSmithKline that will get costlier. Similarly, Sanofi has decided to raise prices of at least 10 drugs and the hikes will be in the range of 1 percent to 5 percent. The drugmaker said that it won’t raise prices of drugs above medical inflation.

Arthritis medication Xeljanz and cancer medication Ibrance manufactured Pfizer are also expected to expensive by around 5 percent. According to Pfizer spokesperson Amy Rose, over 40 percent of drugs that will see an increase in prices are sterile injectables. Some drugs will see a hike of less than USD 1. Another company on the list is Teva Pharmaceutical Industries Ltd. It has increased prices of over 15 medicines and some of them will be more than 6 percent costlier. A company’s spokesperson said that it is a regular affair to review prices in the context of the cost of production, market conditions, and availability. The entire list of drugs that will get costlier is yet to be released.

The United States has higher drug prices when compared to other countries as it leaves pricing to market competition. This has made it the world’s most lucrative market for drug manufacturers. In several countries, drug prices are directly or indirectly controlled by governments. The hike in drug prices comes just days after the Donald Trump administration proposed a rule to allow the import of cheaper medicines from Canada. Trump, a Republican, has failed to deliver on a promise to lower drug prices before the next presidential election. Earlier in December, the House of Representatives passed a bill that would cap prices of some of the most expensive drugs in the United States based on international prices.

The research suggests that baby boys born small for their gestational age have a more casual of sterility as grownups than those born at a normal weight. In the UK, one from the seven heterosexual couples experiences infertility. Figures show that they sense a year or more of demanding a baby without considering it. But the focus is frequently on women’s reproductive health as well as men’s fertility problems are a problem of equal proportion. Both equally responsible for about a third of known reasons for problems in conceiving. The residual third is down to indistinct causes.

Now specialists said they have studied that men have a greater threat of infertility if they took birth with a weight in the lesser than 10% for their time paid in the womb.  Mr. Anne Thorsted, Co-author of the research from Aarhus University in Denmark, said that occasionally, there is a need to look at an early stage to find explanations of health problems. According to the Human Reproduction journal, Mr.Thorsted and co-workers informed how they analyzed health data for nearly 11,000 persons born from 1984 to 1987 in two Danish towns.

Gestational age and birth weight gathered for birth accounts. Two national records officers were used to find out whether persons had identified with sought fertility or infertility treatment up to late of 2017. Just above 10% of both women and men were born lesser for their gestational age. The examination suggested about 8.3% of boys born, which have small for the gestational stage, experienced sterility as grownups linked with 5.7% of those born at a normal weight. However, the connection was no longer seeming once the group left out males who had certain genital difficulties — their urethra presence on the underneath of their penis, or undescended testicles. Research of new teams has earlier found the small weight for gestational age is related to such genital problems. These problems have also connected to fertility problems with lower sperm counts.